Gene · 8456
Papers1,428
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,428
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioactive Compound-Loaded Nanocarriers for Hair Growth Promotion: Current Status and Future Perspectives. | Plants (Basel) | 2023 | 37960095 | PubTator, text mining | PubMed |
| Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases. | Genome Med | 2023 | 37946251 | PubTator, text mining | PubMed |
| CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames. | Nat Struct Mol Biol | 2023 | 37932451 | PubTator, text mining | PubMed |
| Gender Differences in Post-Operative Human Skin. | Biomedicines | 2023 | 37893027 | PubTator, text mining | PubMed |
| Lin28 regulates thymic growth and involution and correlates with MHCII expression in thymic epithelial cells. | Front Immunol | 2023 | 37868985 | PubTator, text mining | PubMed |
| Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody. | Oncoimmunology | 2023 | 37860278 | PubTator, text mining | PubMed |
| Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription. | Sci Adv | 2023 | 37831776 | PubTator, text mining | PubMed |
| Case Report: Characterization of known (c.607G>C) and novel (c.416C>G) ELANE mutations in two Mexican families with congenital neutropenia. | Front Immunol | 2023 | 37795094 | PubTator, text mining | PubMed |
| Omenn syndrome in a 10-month-old male with athymia and VACTERL association. | J Allergy Clin Immunol Glob | 2023 | 37781660 | PubTator, text mining | PubMed |
| The immunology and cell biology of T cell aging. | Semin Immunol | 2023 | 37776667 | PubTator, text mining | PubMed |
| Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma. | J Immunother Cancer | 2023 | 37775116 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Atopic manifestations of inborn errors of immunity. | Curr Opin Allergy Clin Immunol | 2023 | 37755421 | PubTator, text mining | PubMed |
| Development of an in vivo murine model of perineural invasion and spread of cutaneous squamous cell carcinoma of the head and neck. | Front Oncol | 2023 | 37746297 | PubTator, text mining | PubMed |
| A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma. | Cell Death Dis | 2023 | 37736770 | PubTator, text mining | PubMed |
| An Analysis of the Gene Expression Associated with Lymph Node Metastasis in Colorectal Cancer. | Int J Genomics | 2023 | 37719786 | PubTator, text mining | PubMed |
| KMT2A associates with PHF5A-PHF14-HMG20A-RAI1 subcomplex in pancreatic cancer stem cells and epigenetically regulates their characteristics. | Nat Commun | 2023 | 37709746 | PubTator, text mining | PubMed |
| De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8. | Nat Commun | 2023 | 37704610 | PubTator, text mining | PubMed |
| Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer. | BMC Med | 2023 | 37667257 | PubTator, text mining | PubMed |
| Generation of inactivated IL2RG and RAG1 monkeys with severe combined immunodeficiency using base editing. | Signal Transduct Target Ther | 2023 | 37661226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8456/papers?page=5